Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (17)
  • 2024 (21)
  • 2023 (47)
  • 2022 (65)
  • 2021 (56)
  • 2020 (8)
  • 2019 (6)
  • 2018 (1)
  • 2017 (2)
  • 2015 (0)
  • 2003 (1)

Subject

  • Drug Trafficking (1116)
  • Synthetic drugs (374)
  • Guns/Weapons (285)
  • OCDETF/Task Force (196)
  • Seizures (Drugs/Property) (176)
  • Guilty Plea (160)
  • Fake Pills (112)
  • Arrests/Convictions - Major (108)
  • Task Forces/Task Force Officers (105)
  • Overdose (100)
  • Major Law Enforcement Operation (91)
  • Prescription Drugs (84)
  • Diversion Division (54)
  • Outreach/Drug Prevention (48)
  • Gangs (46)
  • Money Laundering (40)
  • Take Back Day (39)
  • HIDTA (30)
  • Press Conferences (25)
  • Public and Media Affairs - also see Congressional Affairs (24)
  • Prevention/Education - DEA websites GSAD, JTT etc (18)
  • Narcoterrorism (16)
  • Extraditions (11)
  • Dark Web- Internet Trafficking (7)
  • International/Foreign Operations (7)
  • Asset Forfeiture (6)
  • Fentanyl Awareness (6)
  • One Pill Can Kill (4)
  • Intergovernmental Affairs (3)
  • Museum and Visitors Center (3)
  • Red Ribbon (2)
  • Congressional Affairs (1)
  • Critical Incident (1)
  • Terrorism (1)
  • Pharmaceuticals/Pharmacists/Physicians (65)

Drug Name

  • Opioids (14)
  • Oxycodone (12)
  • Fentanyl (8)
  • Hydromorphone (6)
  • Benzodiazepines (2)
  • Synthetic Opioids (2)
  • Amphetamines (1)
  • Methamphetamine (1)
  • Morphine (1)
  • Steroids (1)

Field Division

  • Washington, DC (12)
  • St. Louis (10)
  • Miami (7)
  • Chicago (6)
  • New Jersey (6)
  • New York (5)
  • El Paso (4)
  • Houston (4)
  • New England (4)
  • San Diego (2)
  • Atlanta (1)
  • Headquarters (1)
  • Omaha (1)
  • Phoenix (1)
  • Seattle (1)
Clear All Results
PRESS RELEASE

Department of Justice Files Nationwide Lawsuit Against Amerisource Bergen Corp. and Subsidiaries for Controlled Substances Act Violations

December 29, 2022
NEWARK, N.J. – In a civil complaint filed today, the Department of Justice alleges that AmerisourceBergen Corp. and two of its subsidiaries, AmerisourceBergen Drug Corp. and Integrated Commercialization Solutions LLC (AmerisourceBergen), collectively one of the country’s largest wholesale pharmaceutical distributors and one of the largest companies in America by revenue...
December 29, 2022
PRESS RELEASE

Doctor and Office Manager Indicted in Scheme to Defraud Medicare, Manufacture and Distribute Fentanyl

December 16, 2022
SAN DIEGO - Dr. David J. Smith, a pain management physician, and his office manager, Julia Ann Oertle, are charged in a federal grand-jury indictment with perpetuating a long-running scheme to commit healthcare fraud and to manufacture and distribute adulterated fentanyl. Smith made his initial appearance today before U.S. Magistrate...
December 16, 2022
PRESS RELEASE

DEA Serves Order to Show Cause on Truepill Pharmacy for its Involvement in the Unlawful Dispensing of Prescription Stimulants

December 15, 2022
WASHINGTON -- Today, DEA served an Order to Show Cause on Truepill, a retail pharmacy that is alleged to have wrongfully filled thousands of prescriptions for stimulants used in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Truepill was the pharmacy for telehealth companies, including Cerebral, that marketed ADHD treatments, including...
December 15, 2022
PRESS RELEASE

Kansas Pharmacy Agrees to Pay $3 Million for Improperly Dispensing Meds

December 13, 2022
KANSAS CITY, Kan. - PharmScript of KS, LLC, a long-term care pharmacy in Lenexa, Kansas, has agreed to pay $3 million to resolve allegations that it violated federal law by dispensing controlled substances to residents in nursing and long-term care facilities without valid prescriptions and that the company was wrongfully...
December 13, 2022
PRESS RELEASE

Doctor and Eight Others Charged with Distributing Opioids and Other Pills

December 09, 2022
MANHATTAN – Manhattan District Attorney Alvin L. Bragg, Jr., today announced the indictments of nine individuals, including Tribeca physician Dr. Noel Smith, for charges including conspiring to distribute tens of thousands of prescription pills, including opioids and other controlled substances, in Manhattan and Staten Island. The defendants allegedly operated a...
December 09, 2022
PRESS RELEASE

Northeast Hospital Agrees to Pay $1.9 Million To Resolve Allegations of Controlled Substance Recordkeeping Violations

December 07, 2022
BOSTON – Northeast Hospital Corporation (Northeast), part of Beth Israel Lahey Health, has agreed to pay $1.9 million in civil penalties to resolve allegations that Northeast violated the Controlled Substance Act (the CSA) by failing to keep accurate records of controlled substances, including opioids. The CSA requires accurate inventorying and...
December 07, 2022
PRESS RELEASE

Joplin Physician Pleads Guilty to Health Care Fraud

December 02, 2022
SPRINGFIELD, Mo. – A Joplin, Mo., physician pleaded guilty in federal court today to providing false information in order to receive Medicare and Medicaid reimbursements to which she was not entitled. Heather D. Stelling, 55, waived her right to a grand jury and pleaded guilty before U.S. Chief Magistrate Judge...
December 02, 2022
PRESS RELEASE

Dentist and TOBAY Worker Charged in 136-Count Indictment for Opioid Prescription Scheme

November 18, 2022
MINEOLA, N.Y. – Nassau County District Attorney Anne T. Donnelly and Drug Enforcement Administration Special Agent in Charge Frank A. Tarentino III and announced that a Nassau County dentist and a Town of Oyster Bay worker have been indicted for their roles in a scheme to sell opioid prescriptions during...
November 18, 2022
PRESS RELEASE

Wisconsin Doctor Sentenced to 18 Months’ Imprisonment for Drug Crimes

November 03, 2022
MILWAUKEE – John G. McGarry, Assistant Special Agent in Charge of Drug Enforcement Administration-Wisconsin, and U.S. Attorney Gregory J. Haanstad of the Eastern District of Wisconsin announced that on Oct. 27, 2022, Dr. Manuel Thomas, 49, a former pediatrician, had been sentenced by U.S. District Judge Lynn Adelman to 18...
November 03, 2022
PRESS RELEASE

St. Augustine Doctor Indicted for Distributing Controlled Substances

October 31, 2022
JACKSONVILLE, Fla. – United States Attorney Roger B. Handberg announced the return of an indictment charging Scott Andrew Hollington, M.D. (57, St. Augustine) with 10 counts of distribution of controlled substances and one (1) count of conspiracy to distribute controlled substances. If convicted, Hollington faces a maximum penalty of 20...
October 31, 2022
Showing 1 - 10 of 65 results

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster